Clinical Trial

Analysis of Cardiac Biomarker Racial Discrepancies

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
PI no longer with the site
Summary
The goal is to review cardiac biomarkers present on admission between African American patients with new onset Heart Failure compared to a comparable cohort of Caucasian patients to establish whether there is a clinically significant difference between the two groups regarding cardiac biomarker levels and initial Heart Failure severity. Hypothesis: Cardiac biomarker levels in African American patients with new onset Heart Failure with Reduced Ejection Fraction will be significantly lower than a Caucasian cohort with new onset Heart Failure with Reduced Ejection Fraction.
Protocol Amendment History 3 changes
critical Trial status changed: Enrolling by Invitation → Withdrawn 2026-08-05
critical Trial withdrawn: PI no longer with the site 2026-08-05
notable Enrollment reduced: 400 -> 0 participants 2026-08-05
Trial Details
NCT Number NCT05224557
Lead Sponsor Methodist Health System
Conditions Heart Failure
Start Date 2021-09-15
Primary Completion 2027-08-15 (estimated)
Study Completion 2028-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-04